Literature DB >> 30591435

Evolution of Cancer Progression in the Context of Darwinism.

Lukáš Lacina1,2,3, Matúš Čoma4,5, Barbora Dvořánková1,2, Ondřej Kodet1,2,3, Nikola Melegová4, Peter Gál6,5,7, Karel Smetana8,2.   

Abstract

Our review compares evolution of cancer in the human body to the origin of new species from a common ancestor organism with respect to the theory of Charles Darwin. Moreover, the functional role of the tumor microenvironment as a selective pressure actively participating in cancer progression is also demonstrated. Evolutionary aspects of tumor growth and invasion from the point of view of modern therapeutic challenges and opportunities in precision personalized medicine are also discussed. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Tumor microenvironment; cancer ecology; prognosis; regeneration; review; species development; stem cells; wound healing

Mesh：

Year:  2019        PMID： 30591435     DOI： 10.21873/anticanres.13074

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  8 in total

1.  Evolution of multicellularity by collective integration of spatial information.

Authors:  Enrico Sandro Colizzi; Renske Ma Vroomans; Roeland Mh Merks
Journal:  Elife       Date:  2020-10-16       Impact factor: 8.140

Review 2.  Molecular basis of clonal evolution in multiple myeloma.

Authors:  Yusuke Furukawa; Jiro Kikuchi
Journal:  Int J Hematol       Date:  2020-02-06       Impact factor: 2.490

3.  Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer.

Authors:  Tasuku Mariya; Terufumi Kubo; Yoshihiko Hirohashi; Junko Yanagawa; Yuta Tabuchi; Kazuhiko Matsuo; Kiyoshi Furumura; Rena Morita; Munehide Nakatsugawa; Takayuki Kanaseki; Tomohide Tsukahara; Tadashi Hasegawa; Tsuyoshi Saito; Toshihiko Torigoe
Journal:  Med Mol Morphol       Date:  2020-05-14       Impact factor: 2.309

Review 4.  Group Behavior and Emergence of Cancer Drug Resistance.

Authors:  Supriyo Bhattacharya; Atish Mohanty; Srisairam Achuthan; Sourabh Kotnala; Mohit Kumar Jolly; Prakash Kulkarni; Ravi Salgia
Journal:  Trends Cancer       Date:  2021-02-20

5.  Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer.

Authors:  Mohamed Bouchahda; Raphael Saffroy; Abdoulaye Karaboué; Jocelyne Hamelin; Pasquale Innominato; Faouzi Saliba; Francis Lévi; Nelly Bosselut; Antoinette Lemoine
Journal:  JCO Precis Oncol       Date:  2020-09-16

6.  Systematic analysis of the Hippo pathway organization and oncogenic alteration in evolution.

Authors:  Yuxuan Chen; Han Han; Gayoung Seo; Rebecca Elizabeth Vargas; Bing Yang; Kimberly Chuc; Huabin Zhao; Wenqi Wang
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

Review 7.  The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.

Authors:  Ho Won Kang; Wun-Jae Kim; Seok Joong Yun
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

Review 8.  Cancer-Associated Fibroblasts Influence the Biological Properties of Malignant Tumours via Paracrine Secretion and Exosome Production.

Authors:  Martin Vokurka; Lukáš Lacina; Jan Brábek; Michal Kolář; Yi Zhen Ng; Karel Smetana
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.